30 Followers SGX:8YY - Biolidics (SGD 0.325) BIOLIDICS LIMITED
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   
Add Alert 


Yahoo Finance

SGD 0.325    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

19 Oct 2020


Overview

19 Oct 2020

52 Wk Range: 0.175 - 0.885

Day's Range: 0.325 - 0.335

Last Volume: 1,152,100

Current Yield: 0%

Projected Yield: 0%

19 Oct 2020

Metric 8YY S.Median
Beta 0.45 0.25
VaR 57.69 48.01
Liquidity 1.87M 1.01M

Fundamental

19 Oct 2020

PE: NA

Market Cap: 85.8M

Price Over Book: 7.848

Return On Equity: -29.3%

Shares By Insiders: 66%

General

CEO: Man Chun Leong

Founded Year: 2009

Headquarters: Singapore

Sector: Health Technology

Industry: Medical Specialties

Homepage

Description

Biolidics Ltd. operates as a medical technology company. It focuses on the development of cell enrichment systems which, when combined with other analytical tests, have applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The firm has developed and commercialised a fully automated IVD medical device ClearCell FX1, which allows users of the system to perform liquid biopsies to test for the presence of cancer cells. It operates through the following segments: Technical and Product Development, Global Commercial Channel Management, and Corporate. The Technical and Product Development segment involves identifying and assessing collaboration partners and their technology, provision of technical expertise in revenue generating collaboration projects, and product innovation and improvement. The Global Commercial Channel Management segment deals with the management of global distributorship network and direct customers. The Corporate segment refers to the corporate functions in supporting the operations of the group. The company was founded by Johnson Chen on July 19, 2009 and is headquartered in Singapore.